Logo image of CLMB

CLIMB GLOBAL SOLUTIONS INC (CLMB) Stock Analyst Ratings

NASDAQ:CLMB - Nasdaq - US9467601053 - Common Stock

134.97  -1.61 (-1.18%)

Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to CLMB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 138.72. This target is 2.78% above the current price.
CLMB was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CLMB.
In the previous month the buy percentage consensus was at a similar level.
CLMB was analyzed by 7 analysts. More opinions would make the average more meaningful.
CLMB Historical Analyst RatingsCLMB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -26 -24 -22 -20 -18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6

Price Target & Forecast

Price Low Median Mean High 134.97137.36138.72138.72142.80 - 1.77% 2.78% 2.78% 5.80%
CLMB Current Analyst RatingCLMB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2024-12-12 Barrington Research Maintains Outperform -> Outperform
2024-11-12 Barrington Research Maintains Outperform -> Outperform
2024-10-10 Barrington Research Maintains Outperform -> Outperform
2024-08-21 Barrington Research Maintains Outperform -> Outperform
2024-08-09 Barrington Research Maintains Outperform -> Outperform
2024-07-30 Barrington Research Maintains Outperform -> Outperform
2024-05-28 Barrington Research Maintains Outperform -> Outperform
2024-05-06 Barrington Research Maintains Outperform -> Outperform
2024-04-30 Barrington Research Maintains Outperform -> Outperform
2024-03-07 Barrington Research Maintains Outperform -> Outperform
2023-08-04 Barrington Research Reiterate Outperform -> Outperform
2023-07-19 Barrington Research Reiterate Outperform -> Outperform
2023-05-25 Barrington Research Reiterate Outperform
2023-03-22 Barrington Research Maintains Outperform